Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3101
-0.0127 (-3.93%)
At close: Jul 17, 2026, 4:00 PM EDT
0.3145
+0.0044 (1.42%)
After-hours: Jul 17, 2026, 7:56 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $49.5 million as of July 17, 2026. Its market cap has decreased by -82.21% in one year.
Market Cap
49.50M
Enterprise Value
13.27M
1-Year Change
-82.21%
Ranking
Category
Stock Price
$0.31
ChartMarket Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $49.50M, a decrease of -60.35%. That is a compound annual growth rate of -12.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 49.50M | -25.35% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| eXoZymes | 53.25M |
| Veraxa Biotech AG | 53.21M |
| Seres Therapeutics | 52.58M |
| BeyondSpring | 52.22M |
| Filana Therapeutics | 51.93M |
| Immutep | 51.59M |
| INmune Bio | 51.31M |
| Instil Bio | 50.93M |